Caracterización y estandarización de modelos in vitro para el estudio de los mecanismos moleculares las miocardiopatías. (ModinviMio)
Datos básicos
- Código:
- PI24/00202
- Protocolo:
- PI24/00202
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- 52.500,00 €
- Año de incio:
- 2025
- Año de finalización:
- 2027
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
INSTITUTO DE SALUD CARLOS III
Resultados del Ensayo Clínico
Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial
Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers
Article. 10.3389/fcvm.2024.1504427. 2025
Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain.
de Frutos, Fernando; (...); Gonzalez-Costello, Jose
Article. 10.1016/j.rec.2024.12.012. 2025
Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine.
Casas, Guillem; (...); Rodriguez-Palomares, Jose F
Article. 10.1016/j.rec.2025.01.011. 2025
New ECG biomarkers and sex-stratified models for the detection of Arrhythmogenic Cardiomyopathy with left ventricular involvement
Jimenez-Serrano, Santiago; (...); Castells, Francisco
Article. 10.1016/j.bspc.2024.107224. 2025
Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.
Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C
Article. 10.1111/ctr.70027. 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.
Ufnal, Marcin; (...); Rosenkranz, Stephan
Article. 10.1002/ehf2.15203. 2025